COVID-19: all 7,774 studies
Page 73 of 78. Open to participants first (482), then studies with results posted, then the rest; newest registration first within each.
- Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19)TerminatedNCT04363827Phase 2
- Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 InfectionStatus unknownNCT04363814Phase 3
- COVID-19 Infection: Exploration of Respiratory Control Center AbnormalitiesCompletedNCT04363749Not applicable
- Adolescents and Health Professionals Faced With the Necessity for Changing to Remote Care During the COVID-19 Outbreak Quarantine (AdoPro-Cov19)Status unknownNCT04363671
- Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 InfectionCompletedNCT04363632
- The CEDiD Study (COVID-19 Early Diagnosis in Doctors and Healthcare Workers)Status unknownNCT04363489
- Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory DistressCompletedNCT04363463Not applicable
- Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP)Status unknownNCT04363450Phase 3
- Collection of Biological Samples With Clinical Characterization of Covid-19 PatientsTerminatedNCT04363385Not applicable
- A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19WithdrawnNCT04363372Phase 2
- Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With HypoxiaCompletedNCT04363346Phase 1
- ACCESS A Master Digital Surveillance Protocol for COVID-19CompletedNCT04363268
- Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 TreatmentStatus unknownNCT04363216Phase 2
- VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL)SuspendedNCT04363203Phase 3
- Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster.Status unknownNCT04363099
- Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive UnitStatus unknownNCT04363060Phase 3
- Arkansas Expanded Access COVID-19 Convalescent Plasma Treatment ProgramNo longer availableNCT04363034
- St. Jude Tracking of Viral and Host Factors Associated With COVID-19CompletedNCT04362995
- Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) InfectionCompletedNCT04362956
- Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older AdultsCompletedNCT04362943
- Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences)CompletedNCT04362930
- Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 InfectionCompletedNCT04362865
- Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 PneumoniaStatus unknownNCT04362345
- Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19TerminatedNCT04362332Phase 4
- Burnout and Medical Errors in the Anaesthesiology Fraternity During Covid-19 PandemicCompletedNCT04362319
- Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.WithdrawnNCT04362124Phase 3
- Influence of COVID-19 Infection in Thromboembolic Venous Disease: National Cohort StudyStatus unknownNCT04361981
- Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stem CellsCompletedNCT04361942Phase 2
- Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino)TerminatedNCT04361916Not applicable
- Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 InfectionStatus unknownNCT04361903
- Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial)CompletedNCT04361877
- Acral Cutaneous Thrombotic Vasculopathy and Covid-19 InfectionCompletedNCT04361786
- Low-dose Lenalidomide for Non-severe COVID-19 Treatment TrialStatus unknownNCT04361643Phase 4
- COVID-19 in Liver Transplant RecipientsCompletedNCT04361591
- Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 PatientsCompletedNCT04361565
- Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)WithdrawnNCT04361552Phase 3
- Registry of COVID-19 Patients Treated With the Seraph 100 Microbind Affinity Blood FilterStatus unknownNCT04361500
- Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCRTerminatedNCT04361448Not applicable
- Lung Recruitment Device for COVID-19Status unknownNCT04361435Not applicable
- Isotretinoin in Treatment of COVID-19Status unknownNCT04361422Phase 3
- Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 PatientsCompletedNCT04361396Not applicable
- Neurodegeneration Markers and Neurological Course in Severe Covid-19 InfectionTerminatedNCT04361344Not applicable
- Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19Status unknownNCT04361318Phase 2/3
- Leflunomide in Mild COVID-19 PatientsTerminatedNCT04361214Phase 1
- Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in TunisiaStatus unknownNCT04361032Phase 3
- Physical Activity in University Students Around COVID-19 ConfinementCompletedNCT04361019
- The Effects of Standard Protocol With or Without Colchicine in Covid-19 InfectionCompletedNCT04360980Phase 2
- Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical TrialWithdrawnNCT04360876Phase 2
- The Impact of COVID-19 Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong KongStatus unknownNCT04360863
- Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 PandemicCompletedNCT04360850
- PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) PatientsCompletedNCT04360837Not applicable
- Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 PandemicCompletedNCT04360811Not applicable
- Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19WithdrawnNCT04360759Phase 3
- Long Term Outcomes of Patients With COVID-19Active, not recruitingNCT04360538
- Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP)No longer availableNCT04360486
- Ivermectin and Nitazoxanide Combination Therapy for COVID-19Status unknownNCT04360356Phase 2/3
- Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19CompletedNCT04360278
- Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19Status unknownNCT04360122Phase 3
- Study of Hemostasis in Case of Severe COVID-19Status unknownNCT04359992
- Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19TerminatedNCT04359953Phase 3
- Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 RegistryActive, not recruitingNCT04359927
- Neurocognitive Impairment in Patients With COVID-19CompletedNCT04359914
- A Phone-call With a Student/General Practitioner Team to Impact Morbidity of Chronic Patients During COVID-19 ContainmentCompletedNCT04359875Not applicable
- Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 InfectionTerminatedNCT04359862Phase 4
- A Study to Explore the Role of Gut Flora in COVID-19 InfectionSuspendedNCT04359836
- Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With TocilizumabStatus unknownNCT04359667
- Favipiravir in Hospitalized COVID-19 PatientsStatus unknownNCT04359615Phase 4
- Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19Status unknownNCT04359537Phase 2
- Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 PneumoniaWithdrawnNCT04359511Phase 3
- Nasal Epithelial Genetic and Single Cell RNA COVID-19 StudyWithdrawnNCT04359459
- Estrogen Patch for COVID-19 SymptomsTerminatedNCT04359329Phase 2
- Azithromycin in Hospitalized COVID-19 PatientsStatus unknownNCT04359316Phase 4
- Indirect Endovenous Systemic Ozone for New Coronavirus Disease (COVID19) in Non-intubated PatientsStatus unknownNCT04359303Phase 3
- Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDSCompletedNCT04359290Phase 2
- Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled TrialStatus unknownNCT04359264Not applicable
- Different PEEP Settings of COVID-19 Induced ARDSCompletedNCT04359251Not applicable
- Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19CompletedNCT04359212
- COVID-19 and the Developement of Phobic Fears of DiseaseStatus unknownNCT04359121
- Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in ColombiaCompletedNCT04359095Phase 2/3
- Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected PatientsCompletedNCT04358952
- Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19)CompletedNCT04358939Not applicable
- Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19)CompletedNCT04358926Not applicable
- Keto-diet for Intubated Critical Care COVID-19WithdrawnNCT04358835Not applicable
- Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically IllStatus unknownNCT04358809Phase 3
- Baricitinib Therapy in COVID-19CompletedNCT04358614Phase 2/3
- Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19No longer availableNCT04358588
- Classification of COVID-19 Infection in Posteroanterior Chest X-raysCompletedNCT04358536
- COVID-19 Mortality Prediction ModelCompletedNCT04358510
- Liver Injury in Patients With COVID-19Status unknownNCT04358380
- Expanded Access to Convalescent Plasma to Treat and Prevent Pulmonary Complications Associated With COVID-19No longer availableNCT04358211
- PSYCHIATRIC Disorders and Covid-19TerminatedNCT04358042
- Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19)CompletedNCT04358029
- Plasma Adsorption in Patients With Confirmed COVID-19CompletedNCT04358003Not applicable
- Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19CompletedNCT04357990Not applicable
- Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 InfectionsCompletedNCT04357938
- Awareness of COVID-19 in TurkeyCompletedNCT04357886
- Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 InfectionStatus unknownNCT04357847
- WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical TrajectoriesCompletedNCT04357834
- Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID)CompletedNCT04357808Phase 2
- COVID-19 Pandemic Burden in Severe Mental Disease PatientsCompletedNCT04357769